LaurenCarolePinter-BrownMD
Oncology • Los Angeles, CAHematologic Oncology
Professor, Medicine and Dermatology, Chao Family Comprehensive Cancer Center, UC Irvine
Dr. Pinter-Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Medical 420 530 120 Plz
# 365
Los Angeles, CA 90095Phone+1 310-829-5471
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1984 - 1986- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1983 - 1984
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1980 - 1983
David Geffen School of Medicine at UCLAClass of 1980
Certifications & Licensure
CA State Medical License 1981 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Start of enrollment: 2004 Dec 01
- Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma Start of enrollment: 2004 Jul 01
- GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2008 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 103 citationsSézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).Elise A. Olsen, Alain H. Rook, John A. Zic, Youn H. Kim, Pierluigi Porcu
Journal of the American Academy of Dermatology. 2011-02-01 - 323 citationsClinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the Uni...Elise A. Olsen, Sean Whittaker, Youn H. Kim, Madeleine Duvic, H. Miles Prince
Journal of Clinical Oncology. 2011-06-20 - 438 citationsPivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell LymphomaElise A. Olsen, Madeleine Duvic, Arthur E. Frankel, Youn H. Kim, Ann Martin
Journal of Clinical Oncology. 2001-01-15
Journal Articles
- Phase 2 Study of Everolimus for Relapsed or Refractory Classical Hodgkin LymphomaPatrick B. Johnston, Radhakrishnan Ramchandren, Lauren C. Pinter-Brown, BioMed Central
Press Mentions
- SOHO 2021: An Update of Lymphoma Treatments in Five PartsSeptember 20th, 2021
New Publication Offers Insight into POTELIGEO® (Mogamulizumab-Kpkc) Treatment Response in Cutaneous T-cell Lymphoma Patients with Varying Levels of Blood InvolvementJuly 22nd, 2021
Nephrotic Syndrome Reported with Everolimus, VoriconazoleJuly 8th, 2017
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
